Role and dynamics of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in burn patients

被引:2
|
作者
Stanciu, Adina Elena [1 ]
Zamfir-Chiru-Anton, Adina [2 ]
Stanciu, Marcel Marian [3 ]
Gherghe, Mirela [4 ,5 ]
Hainarosie, Razvan [6 ,7 ]
Furtunescu, Florentina Ligia [8 ]
Gheorghe, Dan Cristian [7 ,9 ]
机构
[1] Prof Dr Alexandru Trestioreanu Inst Oncol, Dept Carcinogenesis & Mol Biol, 252 Fundeni St, Bucharest 022328, Romania
[2] Grigore Alexandrescu Childrens Emergency Hosp, ENT Dept, Bucharest 011743, Romania
[3] Politehn Univ, Elect Engn Fac, Bucharest 060042, Romania
[4] Prof Dr Alexandru Trestioreanu Inst Oncol, Dept Nucl Med, Bucharest 022328, Romania
[5] Carol Davila Univ Med & Pharm, Dept Radiol, Bucharest 050463, Romania
[6] Prof Dr Dorin Hociota Inst Phonoaudiol & Funct EN, ENT Dept, Bucharest 050751, Romania
[7] Carol Davila Univ Med & Pharm, ENT Dept, Bucharest 050463, Romania
[8] Carol Davila Univ Med & Pharm, Dept Complementary Sci, 37 Dionisie Lupu St, Bucharest 050463, Romania
[9] Maria Sklodowska Curie Childrens Emergency Hosp, ENT Dept, Bucharest 077120, Romania
关键词
burn injury; biomarkers; MMP-9; TIMP-1; ratio; THERMAL-INJURY; SKIN; HYPERPERMEABILITY; MELATONIN; SEVERITY; MMP-9;
D O I
10.3892/etm.2021.10496
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Burn injuries can trigger tissue changes that can explain the variation in the level of different biochemical markers that can be recorded both locally or systemically. Some events observed in burn wounds such as vascular hyperpermeability have been associated with the release of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) after trauma. Because it is unknown whether the serum levels of MMP-9 and TIMP-1 are a consequence of these destructions or a local response to thermal damage, we decided to follow their dynamics. Twenty-five patients (mean age 49.40 +/- 17.55 years) with a total body surface area (TBSA) affected by a thermal burn of <25% and 30 healthy subjects (mean age 49.70 +/- 8.04 years) were enrolled in the present study. Enzyme immunoassays were used to measure the serum levels of MMP-9 and TIMP-1. Our results showed that MMP-9 was increased 6.25-fold immediately after injury compared to the controls and remained on a plateau throughout the 7-day monitoring period. TIMP-1 showed an upward trend with an increase of 49.52% on the seventh day after triggering insult. The time-course of the MMP-9/TIMP-1 ratio followed the inverse dynamics of TIMP-1 starting from a ratio value measured at admission 3.82-fold higher than the one observed in the healthy volunteers and a highly statistically significant correlation between the values measured at different time-points during the monitoring period (P<0.001). The results of this retrospective study indicate that the MMP-9/TIMP-1 ratio may provide information on local changes over time, starting from the triggering insult, and may be considered as a predictive biomarker of burn evolutivity.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Plasma matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 as prognostic biomarkers in critically ill patients
    Duda, Izabela
    Krzych, Lukasz
    Jedrzejowska-Szypulka, Halina
    Lewin-Kowalik, Joana
    OPEN MEDICINE, 2020, 15 (01): : 50 - 56
  • [22] CELL DISTRIBUTION DIFFERENCES OF MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE-1 IN PATIENTS WITH KAWASAKI DISEASE
    Korematsu, Seigo
    Ohta, Yoko
    Tamai, Naotaka
    Takeguchi, Masahiro
    Goto, Chika
    Miyahara, Hiroaki
    Kawano, Tatsuya
    Izumi, Tatsuro
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (09) : 973 - 974
  • [23] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    AMERICAN HEART JOURNAL, 2006, 152 (01)
  • [24] Imbalance between tissue inhibitor of metalloproteinase 1 and matrix metalloproteinase 9 after cardiopulmonary resuscitation
    Li, Jing-sha
    Zhong, Jing-quan
    Liu, Hong-zhen
    Zeng, Qi-xian
    Meng, Xiang-lin
    Liu, Dong-lin
    Su, Guo-ying
    Zhang, Yun
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2012, 30 (07): : 1202 - 1209
  • [25] Urinary levels of matrix metalloproteinase 9 and 2 and tissue inhibitor of matrix metalloproteinase in patients with coronary artery disease
    Fitzsimmons, Patrick J.
    Forough, Reza
    Lawrence, Mark E.
    Gantt, D. Scott
    Rajab, M. Hasan
    Kim, Hyunsun
    Weylie, Brian
    Spiekerman, A. Michael
    Dehmer, Gregory J.
    ATHEROSCLEROSIS, 2007, 194 (01) : 196 - 203
  • [26] Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure
    George, J
    Patal, S
    Wexler, D
    Roth, A
    Sheps, D
    Keren, G
    AMERICAN HEART JOURNAL, 2005, 150 (03) : 484 - 487
  • [27] The Balance of Tissue Inhibitor of Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Autoimmune Inner Ear Disease Patients
    Eisner, Logan
    Vambutas, Andrea
    Pathak, Shresh
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2017, 37 (08): : 354 - 361
  • [28] Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in patients with familial Mediterranean fever
    Dinc, Mustafa
    Tanoglu, Alpaslan
    Yazgan, Yusuf
    Beyazit, Yavuz
    Oncu, Kemal
    Onem, Yalcin
    Hira, Serdar
    Kaplan, Mustafa
    Kucuk, Irfan
    Sakin, Yusuf Serdar
    Demirturk, Levent
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2015, 26 (06): : 487 - 491
  • [29] SIGNIFICANCE OF SERUM MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 IN CHRONIC HEPATITIS C PATIENTS
    Badra, Gamal
    Lotfy, Mahmoud
    El-Refaie, Amany
    Obada, Moanis
    Abdelmonem, Elhamy
    Kandeel, Samia
    Fathy, Amr
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2010, 57 (01) : 29 - 42
  • [30] Patients with acute coronary syndromes have increased levels of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1
    Manginas, A
    Bel, E
    Pilatis, N
    Chaidaroglou, A
    Degiannis, D
    Koniavitou, E
    Gokkinos, DV
    CIRCULATION, 2002, 106 (19) : 695 - 695